Expression of insulin-like growth factor 1 in sarcomas

Histopathology. 1990 May;16(5):455-60. doi: 10.1111/j.1365-2559.1990.tb01544.x.

Abstract

The expression of insulin-like growth factor-1 (IGF-1) was studied in normal tissues, in eight benign lesions and in 50 sarcomas. In palmar fibromatosis the spindle cells in cell-dense areas exhibited a strong immunoreactivity. IGF-1 was variably found in leiomyosarcomas (7/8), malignant schwannomas (7/9), synovial sarcomas (2/3), liposarcomas (3/6), fibrosarcomas (1/3), malignant fibrous histiocytomas (10/18) and in one angiosarcoma. Two rhabdomyosarcomas failed to express IGF-1 and only the spindle cell component of synovial sarcomas was positive. Immunoreactivity for IGF-1 in 10 malignant filrous histiocytomas (MFH) appeared to be related to co-expression of smooth muscle actin. These findings imply that MFHs can be subdivided into a group of tumours which are devoid of morphological and immunophenotypic evidence of differentiation and a group which manifest immunophenotypic differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Biomarkers, Tumor / metabolism
  • Desmin / metabolism
  • Histiocytoma, Benign Fibrous / metabolism
  • Histiocytoma, Benign Fibrous / pathology
  • Humans
  • Immunohistochemistry
  • Insulin-Like Growth Factor I / metabolism*
  • Sarcoma / classification
  • Sarcoma / metabolism*
  • Sarcoma / pathology
  • Somatomedins / metabolism*

Substances

  • Actins
  • Biomarkers, Tumor
  • Desmin
  • Somatomedins
  • Insulin-Like Growth Factor I